Medicare Enrolled
Dr. Christopher Lobo, MD
Medical Oncology · Port Charlotte, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lobo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lobo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lobo
Dr. Christopher Lobo is a medical oncology specialist in Port Charlotte, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lobo performed 507,683 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lobo received a total of $6,078 from 61 pharmaceutical and/or device companies across 349 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lobo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 1% volume in FL
$6,078 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 89074 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗507,683
Medicare services
Top 1% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
79,100 | $0 | $5 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
47,940 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 37,600 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 37,570 | $1 | $5 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
37,320 | $0 | $1 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
34,860 | $0 | $2 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
34,100 | $0 | $12 |
| Nivolumab injection (Opdivo) | 32,720 | $24 | $72 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
24,120 | $38 | $110 |
| Denosumab injection (Prolia/Xgeva) | 20,520 | $18 | $51 |
| Paclitaxel chemotherapy injection | 20,044 | $0 | $2 |
| Injection, durvalumab, 10 mg | 10,976 | $62 | $191 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
9,792 | $36 | $108 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
8,984 | $0 | $3 |
| Injection, mepolizumab, 1 mg | 8,100 | $23 | $72 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
7,139 | $6 | $23 |
| Injection, docetaxel, 1 mg | 5,488 | $1 | $7 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
5,002 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
4,713 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 4,570 | $1 | $28 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
3,828 | $26 | $116 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
3,255 | $4 | $113 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
2,975 | $34 | $140 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,852 | $95 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 2,516 | $0 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
2,508 | $12 | $61 |
| Omalizumab injection (Xolair) for asthma/allergy | 2,190 | $30 | $95 |
| Injection, leucovorin calcium, per 50 mg | 1,772 | $3 | $12 |
| Injection, fulvestrant, 25 mg | 1,500 | $8 | $132 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,426 | $10 | $69 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
1,320 | $97 | $378 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
1,130 | $2 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
834 | $47 | $189 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
624 | $1 | $3 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
581 | $2 | $41 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
580 | $2 | $13 |
| Injection, potassium chloride, per 2 meq | 480 | $0 | $4 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
472 | $10 | $42 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
434 | $21 | $79 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
387 | $2 | $7 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
362 | $16 | $59 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
359 | $49 | $178 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 359 | $3 | $205 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
324 | $1 | $6 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
308 | $15 | $56 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
275 | $55 | $206 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
271 | $21 | $84 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
268 | $28 | $156 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
228 | $0 | $3 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
228 | $1 | $2 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
192 | $123 | $453 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
183 | $25 | $89 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
180 | $3 | $11 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
176 | $126 | $637 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
163 | $24 | $156 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 147 | $135 | $562 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
145 | $42 | $170 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
132 | $4 | $15 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
117 | $4 | $10 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
112 | $15 | $56 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
96 | $2 | $8 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
93 | $62 | $197 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
83 | $6 | $69 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
79 | $1 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $67 | $239 |
| New patient office visit, complex (60-74 min) | 68 | $164 | $585 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
62 | $4 | $15 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
61 | $65 | $277 |
| Injection, furosemide, up to 20 mg | 61 | $0 | $9 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
59 | $5 | $20 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
46 | $137 | $556 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
35 | $140 | $474 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
17 | $214 | $722 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
12.7% high complexity
84.4% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,078
Total received (2018-2024)
Avg $868/year across 7 years
Bottom 48% in FL for medical oncology
61
Companies
349
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$876
2023
$854
2022
$912
2021
$708
2020
$585
2019
$830
2018
$1,313
Payments by company (2024)
Janssen Biotech, Inc.
$137
Adaptive Biotechnologies Corporation
$118
BeiGene USA, Inc.
$93
Regeneron Healthcare Solutions, Inc.
$69
Takeda Pharmaceuticals U.S.A., Inc.
$66
Daiichi Sankyo Inc.
$59
E.R. Squibb & Sons, L.L.C.
$55
PFIZER INC.
$50
ARRAY BIOPHARMA INC
$47
Celgene Corporation
$40
Mirati Therapeutics, Inc.
$38
Eisai Inc.
$24
PharmaEssentia USA Corporation
$24
Alnylam Pharmaceuticals Inc.
$20
Merck Sharp & Dohme LLC
$19
Novartis Pharmaceuticals Corporation
$14
Top 3 companies account for 39.7% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$898
Janssen Biotech, Inc.
$642
Novartis Pharmaceuticals Corporation
$532
Merck Sharp & Dohme Corporation
$396
PFIZER INC.
$384
Celgene Corporation
$382
Daiichi Sankyo Inc.
$178
Lilly USA, LLC
$151
BeiGene USA, Inc.
$143
Astellas Pharma US Inc
$136
Regeneron Healthcare Solutions, Inc.
$128
Adamas Pharmaceuticals, Inc.
$125
Adaptive Biotechnologies Corporation
$118
ARRAY BIOPHARMA INC
$110
Merck Sharp & Dohme LLC
$105
Exelixis Inc.
$103
Genentech USA, Inc.
$101
Takeda Pharmaceuticals U.S.A., Inc.
$92
Incyte Corporation
$91
Seagen Inc.
$86
NanoString Technologies, Inc.
$72
PharmaEssentia USA Corporation
$70
Amgen Inc.
$66
AbbVie, Inc.
$62
Myovant Sciences Inc.
$61
ABBVIE INC.
$59
Eisai Inc.
$49
GENZYME CORPORATION
$46
Gilead Sciences, Inc.
$42
Mirati Therapeutics, Inc.
$38
AstraZeneca Pharmaceuticals LP
$38
Karyopharm Therapeutics Inc.
$34
AbbVie Inc.
$32
Secura Bio, Inc.
$32
GlaxoSmithKline, LLC.
$31
EMD Serono, Inc.
$30
TerSera Therapeutics LLC
$26
Telix Pharmaceuticals
$25
JAZZ PHARMACEUTICALS INC.
$24
Spectrum Pharmaceuticals Inc.
$24
TESARO, Inc.
$23
Pharmacyclics LLC, An AbbVie Company
$23
GE HealthCare
$22
Genmab U.S., Inc.
$22
Alnylam Pharmaceuticals Inc.
$20
Heron Therapeutics, Inc.
$18
Sun Pharmaceutical Industries Inc.
$17
Puma Biotechnology, Inc.
$17
Immunomedics, Inc.
$16
CTI BioPharma Corp.
$15
Sysmex Inostics Inc
$15
Horizon Pharma plc
$14
Jazz Pharmaceuticals Inc.
$14
SANOFI-AVENTIS U.S. LLC
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
Taiho Oncology, Inc.
$12
Epizyme, Inc.,
$12
Aurobindo Pharma USA, Inc.
$12
SECURA BIO, INC.
$11
Rigel Pharmaceuticals, Inc.
$5
Veracyte, Inc.
$1
Top 3 companies account for 34.1% of all-time payments
Associated products mentioned in payments ›
ALIMTA · Alecensa · Avastin · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COPIKTRA · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ERLEADA · Enhertu · Epkinly · Erleada · FARYDAK · FRUZAQLA · Farydak · Folotyn · GIVLAARI · GOCOVRI · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LORBRENA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · NINLARO · Nerlynx · Neulasta · Nplate · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PEMAZYRE · PLUVICTO · PROMACTA · PROSIGNA ASSAY · Padcev · Perjeta · Phesgo · Pomalyst · REBLOZYL · RYBREVANT · Rezlidhia · SANDOSTATIN · SARCLISA · SPRYCEL · SUTENT · TASIGNA · TAZVERIK · TECVAYLI · TEVIMBRA · TIVDAK · Trodelvy · VARUBI · VENCLEXTA · VOTRIENT · Venclexta · Vonjo · XALKORI · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · YONSA · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
5
County median income
$66,154
Nearest hospital to ZIP centroid (approximate)
Adventhealth Port Charlotte
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lobo is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lobo experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Lobo performed 79,100 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lobo receive payments from pharmaceutical companies?
Yes. Dr. Lobo received a total of $6,078 from 61 companies across 349 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lobo's costs compare to other medical oncologists in Port Charlotte?
Dr. Lobo's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lobo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Port Charlotte
Browse medical oncologists in Port Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology